KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Eli Lilly (LLY) Assets Average (2016 - 2026)

Eli Lilly filings provide 18 years of Assets Average readings, the most recent being $114.5 billion for Q1 2026.

  • On a quarterly basis, Assets Average rose 36.26% to $114.5 billion in Q1 2026 year-over-year; TTM through Mar 2026 was $114.5 billion, a 36.26% increase, with the full-year FY2025 number at $95.6 billion, up 33.96% from a year prior.
  • Assets Average hit $114.5 billion in Q1 2026 for Eli Lilly, up from $113.7 billion in the prior quarter.
  • In the past five years, Assets Average ranged from a high of $114.5 billion in Q1 2026 to a low of $47.0 billion in Q2 2022.
  • Median Assets Average over the past 5 years was $64.0 billion (2024), compared with a mean of $71.3 billion.
  • Biggest five-year swings in Assets Average: dropped 1.53% in 2022 and later skyrocketed 47.36% in 2025.
  • Eli Lilly's Assets Average stood at $48.5 billion in 2022, then grew by 25.76% to $61.0 billion in 2023, then rose by 26.57% to $77.2 billion in 2024, then surged by 47.36% to $113.7 billion in 2025, then increased by 0.72% to $114.5 billion in 2026.
  • The last three reported values for Assets Average were $114.5 billion (Q1 2026), $113.7 billion (Q4 2025), and $107.9 billion (Q3 2025) per Business Quant data.